{
  "pmcid": "10633416",
  "sha256": "1a549794264870f99aa696b4cea2f00ecab6a00335e942571d41725c458df6fa",
  "timestamp_utc": "2025-11-09T23:08:05.434035+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.698915906788248,
    "reading_ease": 35.10500000000002,
    "word_count": 282
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Laser Epilation in Pilonidal Disease: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants aged 11 to 21 years with pilonidal disease were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants aged 11 to 21 years with pilonidal disease were randomised to receive either laser epilation (LE) with standard care or standard care alone."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants aged 11 to 21 years with pilonidal disease were randomised to receive either laser epilation (LE) with standard care or standard care alone."
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the recurrence rate of pilonidal disease at 1 year."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not specified."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 302 participants were randomised: 151 to the LE group and 151 to the standard care group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "One-year follow-up data were available for 96 patients in the LE group and 134 in the standard care group."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The recurrence rate was significantly lower in the LE group (−23.2%; 95% CI, −33.2 to −13.1; P < .001)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Adverse events were not reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial Registration: ClinicalTrials.gov Identifier: NCT03276065"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}